EMPIRE GENOMICS

As new drugs are developed that target specific gene mutations, new diagnostic tests also need to be available to determine if those drugs will have a positive outcome for a patient. At Empire Genomics, we are working with leading research and clinical institutions to bring those diagnostic tests to market faster than any other competitor. Over the past year, our access to Roswell Parks BAC library has enabled us to develop and sell highly specific tests for drugs that target NTRK for solid tumors and ABL1 for pediatric leukemias within weeks compared to the months typically required... Our mission is to improve individual patient care through the integration of innovative molecular diagnostic technology, manufacturing genetic tests for over 200 different types of health concerns.

Also known as: Empire Genomics Corp, Empire Genomics, Inc.

Primary location: Depew United States